Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
BACKGROUND: Few data are available for patients with a late onset (≥ 50 years) of neuromyelitis optica (LONMO) or neuromyelitis optica spectrum disease (LONMOSD), defined by an optic neuritis/longitudinally extensive transverse myelitis with aquaporin-4 antibodies (AQP4-Ab). OBJECTIVE: To characteri...
Main Authors: | Collongues, N, Marignier, R, Jacob, A, Leite, M, Siva, A, Paul, F, Zephir, H, Akman-Demir, G, Elsone, L, Jarius, S, Papeix, C, Mutch, K, Saip, S, Wildemann, B, Kitley, J, Karabudak, R, Aktas, O, Kuscu, D, Altintas, A, Palace, J, Confavreux, C, De Seze, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
SAGE Publications
2013
|
Similar Items
-
Use of mitoxantrone in neuromyelitis optica.
by: Kitley, J, et al.
Published: (2011) -
Seasonal pattern of variation in neuromyelitis optica relapses
by: Elsone, L, et al.
Published: (2012) -
TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
by: Elsone, L, et al.
Published: (2012) -
Treatment of Neuromyelitis Optica: Review and Recommendations.
by: Kimbrough, D, et al.
Published: (2012) -
Treatment of neuromyelitis optica: Review and recommendations
by: Kimbrough, D, et al.
Published: (2012)